{"entity":{"id":"paper-khoperia-liver-cancer-hcv-elimination-georgia-plosone-2026","kind":"paper","name":"Primary liver cancer in Georgia in the first seven years of the Hepatitis C Elimination Program","aka":[],"tldr":"Linking Georgia's cancer registry, death records and hepatitis C programme data for 2015 to 2022 showed that most people with liver cancer and active hepatitis C had already been treated for it, many more than a year before the cancer was found.","summary":"Published as \"Primary liver cancer in Georgia: Seven years' experience following the launch of the Hepatitis C Elimination Program, 2015-2022\". Georgia launched a national Hepatitis C Elimination Program in 2015. The authors, led from the National Center for Disease Control and Public Health, linked the Georgian Cancer Registry, the national vital registration system and the elimination programme's databases to describe adult primary liver cancers diagnosed from January 2015 to December 2022.","asOf":"2026-11-11","links":[{"label":"PLOS ONE 2026","url":"https://doi.org/10.1371/journal.pone.0347697"},{"label":"PubMed","url":"https://pubmed.ncbi.nlm.nih.gov/42048314/"}],"tags":[],"related":[],"cancers":["hcc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["ncdc-georgia","georgia-population-cancer-registry"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"journal":"PLOS ONE","year":2026,"doi":"10.1371/journal.pone.0347697","pmid":"42048314","authors":"Khoperia A, Gawel SH, Bedrava J, et al.","paperType":"real-world","findings":["Of 1,734 primary liver cancers, 72.0% were in men (median age 63); two thirds were stage 3 or 4 and 80.2% of patients had died by the end of 2022.","Testing for hepatitis C among liver cancer patients rose from 14.0% in 2015 to 92.8% in 2022; 56.5% of those tested were antibody positive and 654 had active infection.","Of the 654, 75.7% started hepatitis C treatment, 71.7% of them more than a year before the liver cancer diagnosis."],"whatItMeans":"Curing hepatitis C does not remove liver cancer risk for people who already have cirrhosis; the authors call for routine follow-up of treated cirrhotic patients so liver cancer is found earlier.","caveats":["Descriptive; registry linkage depends on matching quality.","Not everyone with liver cancer was tested for hepatitis C, especially in the early years."],"participants":1734},"route":"/key-papers/paper-khoperia-liver-cancer-hcv-elimination-georgia-plosone-2026/","neighbours":{"cancer":[{"id":"hcc","kind":"cancer","name":"Hepatocellular carcinoma","route":"/cancers/hcc/"}],"institution":[{"id":"georgia-population-cancer-registry","kind":"institution","name":"Georgia Population-Based Cancer Registry","route":"/institutions/georgia-population-cancer-registry/"},{"id":"georgia-ministry-of-health","kind":"institution","name":"Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia","route":"/institutions/georgia-ministry-of-health/"},{"id":"ncdc-georgia","kind":"institution","name":"National Center for Disease Control and Public Health (Georgia)","route":"/institutions/ncdc-georgia/"}]}}